₹151 Cr market cap. Stock price ₹44.3. Up 17.4% in 3 months and 64.9% in 1 year. P/E 63.3. Price-to-book 12.8. ROE 24.8%. ROCE 16.3%. Debt-to-equity 2.22. Quarterly sales ₹10.04 Cr. Quarterly PAT ₹-2.62 Cr.
Ladies and gentlemen, welcome to India’s most dramatic mushroom farm. One quarter it posts ₹3.15 Cr profit, next quarter it serves a ₹-2.62 Cr loss. Operating margin? -74.6% in the latest quarter. Yes, minus seventy-four percent. That’s not a typo. That’s a horror movie.
Despite that, the stock is trading at 63 times earnings. Because apparently mushrooms are not vegetables — they are expectations.
Is this a comeback story? A trading pivot? Or just agricultural turbulence?
Let’s enter the compost pile and find out.
2. Introduction – The Curious Case of the Cultivated Comeback